Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

14.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning-Optimized Single-Atom Catalysts Enable Microenvironment-Adaptive Chemodynamic-Bioorthogonal Cancer Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Advanced High-Entropy Biomaterials (HEBs).

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Piezoelectric Nanozymes With Acoustically Rejuvenated Catalytic Activities Rewire Lipid Metabolism for Two-Pronged Ferroptotic Therapy.

Angewandte Chemie (International ed. in English)·2026
Same author

Quantum Nanomedicine and Quantum Biomaterials.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Mechanically-driven expandable patch promotes tracheal defect reconstruction via synergistic microcurrent and mechanical force cascades.

Nature communications·2026
Same author

Dual Single-Atom Engineered NADH Oxidase-Mimic Boosts In Situ NAD<sup>+</sup> Biotransformation for Targeted Myocardial Ischemia/Reperfusion Protection.

Advanced materials (Deerfield Beach, Fla.)·2026

Related Experiment Video

Updated: Jun 21, 2025

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

22.0K

Microbe-material hybrids for therapeutic applications.

Meng Chen1,2, Lili Xia1, Chenyao Wu1

  • 1Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China. fengw@shu.edu.cn.

Chemical Society Reviews
|July 15, 2024
PubMed
Summary

Microbe-material hybrids leverage unique microbial properties for advanced nanomedicine. These living biomaterials offer enhanced drug delivery and therapeutic potential for various diseases.

More Related Videos

Photodegradable Hydrogel Interfaces for Bacteria Screening, Selection, and Isolation
07:28

Photodegradable Hydrogel Interfaces for Bacteria Screening, Selection, and Isolation

Published on: November 4, 2021

2.8K
Biomimetic Materials to Characterize Bacteria-host Interactions
12:22

Biomimetic Materials to Characterize Bacteria-host Interactions

Published on: November 16, 2015

9.3K

Related Experiment Videos

Last Updated: Jun 21, 2025

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

22.0K
Photodegradable Hydrogel Interfaces for Bacteria Screening, Selection, and Isolation
07:28

Photodegradable Hydrogel Interfaces for Bacteria Screening, Selection, and Isolation

Published on: November 4, 2021

2.8K
Biomimetic Materials to Characterize Bacteria-host Interactions
12:22

Biomimetic Materials to Characterize Bacteria-host Interactions

Published on: November 16, 2015

9.3K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Microbiology

Background:

  • Microorganisms are natural living substances utilized in medicine for creating microbe-material hybrids.
  • Engineering microbe-involved nanomedicine harnesses unique microbial physiological attributes, including hypoxia tendency and oxygen production.
  • These properties enable synergistic enhancements for improved drug delivery, site-specific therapy, and treatment monitoring.

Purpose of the Study:

  • To review microorganisms and microbial derivatives used in biomedicine.
  • To outline strategies for constructing microbe-material hybrids.
  • To illustrate diverse biomedical applications and discuss clinical translation challenges.

Main Methods:

  • Literature review of microorganisms and microbial derivatives in biomedicine.
  • Delineation of strategies and mechanisms for constructing microbe-material hybrids.
  • Exhaustive illustration of biomedical applications, including bioimaging and various therapies.

Main Results:

  • Microbe-material hybrids offer synergistic enhancements for therapeutic applications.
  • Diverse applications include bioimaging, anti-tumor, anti-bacterial, and anti-inflammatory therapies.
  • Microbe-material hybrids show promise for next-generation nanomedicine with theranostic properties.

Conclusions:

  • Microbe-material hybrids present substantial opportunities for amplifying disease treatment efficacy.
  • The unique versatility of these hybrids positions them as promising candidates for advanced nanomedicine.
  • Further research into clinical translation is needed to realize their full potential.